BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9132315)

  • 21. [Cutaneous and haematological adverse events after methotrexate therapy].
    Rossau AK; Pedersen PT; Bygum A
    Ugeskr Laeger; 2015 Jan; 177(4):V65620. PubMed ID: 25613207
    [No Abstract]   [Full Text] [Related]  

  • 22. The facts about methotrexate in rheumatoid arthritis.
    Bannwarth B; Vernhes JP; Schaeverbeke T; Dehais J
    Rev Rhum Engl Ed; 1995; 62(7-8):471-3. PubMed ID: 8574608
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
    Livermore PA; Murray KJ
    Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
    [No Abstract]   [Full Text] [Related]  

  • 24. Pneumonitis induced by methotrexate in a patient with seronegative rheumatoid arthritis.
    Fernández Matilla M; Fernández-Llanio Comella N; Castellano Cuesta JA
    Reumatol Clin; 2015; 11(3):190-1. PubMed ID: 25631247
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine.
    Blanco R; Martínez-Taboada VM; González-Gay MA; Armona J; Fernández-Sueiro JL; González-Vela MC; Rodríguez-Valverde V
    Arthritis Rheum; 1996 Jun; 39(6):1016-20. PubMed ID: 8651964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment X-rays for rheumatoid arthritis treated with methotrexate.
    Richards AJ
    Br J Rheumatol; 1997 Nov; 36(11):1234-5. PubMed ID: 9402875
    [No Abstract]   [Full Text] [Related]  

  • 27. Methotrexate pneumonitis in a patient with rheumatoid arthritis.
    Clearkin R; Corris PA; Thomas SH
    Postgrad Med J; 1997 Sep; 73(863):603-4. PubMed ID: 9373613
    [No Abstract]   [Full Text] [Related]  

  • 28. Angio-neurotic oedema associated with methotrexate treatment in rheumatoid arthritis.
    Freeman AM; Dasgupta B
    Rheumatology (Oxford); 1999 Sep; 38(9):908. PubMed ID: 10515658
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity.
    Landewé RB; van den Borne BE; Breedveld FC; Dijkmans BA
    Lancet; 2000 May; 355(9215):1616-7. PubMed ID: 10821370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment: severe pancytopenia associated with methotrexate therapy for rheumatoid arthritis.
    Mofredj A; Baraka D; Charoud A
    Ann Pharmacother; 2002; 36(7-8):1295. PubMed ID: 12086573
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment.
    Shoda H; Inokuma S; Yajima N; Tanaka Y; Setoguchi K
    Ann Rheum Dis; 2005 Apr; 64(4):651-2. PubMed ID: 15769928
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 1. Methotrexate].
    Suzuki Y; Chinen N
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2902-9. PubMed ID: 22175129
    [No Abstract]   [Full Text] [Related]  

  • 33. Is methotrexate oncogenic in patients with rheumatoid arthritis?
    Kremer JM
    Semin Arthritis Rheum; 1997 Jun; 26(6):785-7. PubMed ID: 9213376
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple malignant melanomas in a patient with RA treated with methotrexate.
    Potter T; Hardwick N; Mulherin D
    J Rheumatol; 1998 Nov; 25(11):2282-3. PubMed ID: 9818680
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rheumatoid arthritis and polycythemia vera JAK2 negative association: Polycythemia may be worsening under methotrexate?].
    Saidane O; Sellami M; Mahmoud I; Ben Tekaya A; Tekaya R; Abdelmoula L
    Therapie; 2018 Sep; 73(4):351-353. PubMed ID: 29373131
    [No Abstract]   [Full Text] [Related]  

  • 36. Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease.
    Inokuma S; Kono H; Kohno Y; Hiramatsu K; Ito K; Shiratori K; Yamazaki J; Nakayama H; Shoda H; Tanaka Y
    Ann Rheum Dis; 2006 Aug; 65(8):1113-4. PubMed ID: 16837494
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversible leukoencephalopathy after oral methotrexate.
    Koppen H; Wessels JA; Ewals JA; Treurniet FE
    J Rheumatol; 2012 Sep; 39(9):1906-7. PubMed ID: 22942312
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methotrexate in rheumatology: a therapeutic revolution].
    Kaye O; Ribbens C; Hauwaert C; Malaise MG
    Rev Med Liege; 1995 Nov; 50(11):453-7. PubMed ID: 8532990
    [No Abstract]   [Full Text] [Related]  

  • 39. Quinine-induced cutaneous vasculitis.
    Price EJ; Bevan JS; Rees A
    Br J Clin Pract; 1992; 46(2):138-9. PubMed ID: 1457303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated nodulosis during methotrexate therapy for refractory rheumatoid arthritis. A case report.
    Filosa G; Salaffi F; Bugatti L
    Adv Exp Med Biol; 1999; 455():521-4. PubMed ID: 10599392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.